CompletedNCT01003691
Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy
PHASE1 · 24 planned enrolment
- Countries listed
- 1
- Registry update
- May 12, 2022
Registry Intervention View
RN6G
Trial registrations containing the exact intervention label RN6G.
Exact registry label · Not reported
3 linked registrations
No aliases or equivalent products have been inferred.
Topics connected by trial metadata
3 linked registrations report posted results
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →Registered trials
TerminatedNCT01577381
Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration
PHASE2 · 10 planned enrolment
- Countries listed
- 1
- Registry update
- March 16, 2016
CompletedNCT00877032
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
PHASE1 · 57 planned enrolment
- Countries listed
- 1
- Registry update
- March 31, 2015